Hong Seng Consolidated Berhad Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Hong Seng Consolidated Berhad has been growing earnings at an average annual rate of 22.2%, while the Healthcare industry saw earnings growing at 24.3% annually. Revenues have been growing at an average rate of 33.2% per year.
Belangrijke informatie
22.2%
Groei van de winst
35.5%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 31.5% |
| Inkomstengroei | 33.2% |
| Rendement op eigen vermogen | -21.9% |
| Nettomarge | -409.6% |
| Laatste winstupdate | 31 Mar 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Hong Seng Consolidated Berhad (KLSE:HONGSENG) Has Debt But No Earnings; Should You Worry?
Sep 23
Health Check: How Prudently Does Hong Seng Consolidated Berhad (KLSE:HONGSENG) Use Debt?
Jun 09Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) Weighed On By Its Debt Load?
Oct 12Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) A Risky Investment?
May 11We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Can Stay On Top Of Its Debt
Jan 27Here's Why We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Is Well Worth Watching
Jan 04Investors Shouldn't Be Too Comfortable With Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Robust Earnings
Nov 30Shareholders Would Enjoy A Repeat Of Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Recent Growth In Returns
Oct 26Hong Seng Consolidated Berhad (KLSE:HONGSENG) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely
Aug 31We Ran A Stock Scan For Earnings Growth And Hong Seng Consolidated Berhad (KLSE:HONGSENG) Passed With Ease
Aug 09Opbrengsten en kosten
Hoe Hong Seng Consolidated Berhad geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Mar 24 | 15 | -61 | 14 | 0 |
| 30 Jun 23 | 9 | -27 | 17 | 0 |
| 31 Mar 23 | 12 | -3 | 19 | 0 |
| 31 Dec 22 | 126 | 49 | 23 | 0 |
| 30 Sep 22 | 198 | 97 | 25 | 0 |
| 30 Jun 22 | 257 | 135 | 24 | 0 |
| 31 Mar 22 | 258 | 118 | 21 | 0 |
| 31 Dec 21 | 196 | 82 | 17 | 0 |
| 30 Sep 21 | 146 | 44 | 12 | 0 |
| 31 Dec 20 | 27 | -4 | 5 | 0 |
| 30 Sep 20 | 2 | -7 | 5 | 0 |
| 30 Jun 20 | 3 | -8 | 4 | 0 |
| 31 Mar 20 | 4 | -7 | 5 | 0 |
| 31 Dec 19 | 5 | -7 | 2 | 0 |
| 30 Sep 19 | 8 | -13 | 4 | 0 |
| 30 Jun 19 | 10 | -14 | 4 | 0 |
| 31 Mar 19 | 10 | -13 | 6 | 0 |
| 31 Dec 18 | 16 | -26 | 6 | 0 |
| 30 Sep 18 | 24 | -20 | 6 | 0 |
| 30 Jun 18 | 26 | -24 | 8 | 0 |
| 31 Mar 18 | 29 | -27 | 9 | 0 |
| 31 Dec 17 | 27 | -10 | 15 | 0 |
| 30 Sep 17 | 27 | -12 | 14 | 0 |
| 30 Jun 17 | 29 | -11 | 14 | 0 |
| 31 Mar 17 | 30 | -8 | 12 | 0 |
| 31 Dec 16 | 31 | -8 | 12 | 0 |
| 30 Sep 16 | 38 | -3 | 14 | 0 |
| 30 Jun 16 | 39 | 1 | 13 | 0 |
| 31 Mar 16 | 42 | 2 | 14 | 0 |
| 31 Dec 15 | 42 | 4 | 14 | 0 |
| 30 Sep 15 | 39 | -2 | 12 | 0 |
| 30 Jun 15 | 39 | -5 | 15 | 0 |
| 31 Mar 15 | 38 | -5 | 16 | 0 |
| 31 Dec 14 | 36 | -9 | 18 | 0 |
| 30 Sep 14 | 33 | -2 | 16 | 0 |
| 30 Jun 14 | 35 | 1 | 16 | 0 |
| 31 Mar 14 | 34 | 2 | 16 | 0 |
| 31 Dec 13 | 34 | 4 | 16 | 0 |
Kwaliteitswinsten: HONGSENG is currently unprofitable.
Groeiende winstmarge: HONGSENG is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: HONGSENG is unprofitable, but has reduced losses over the past 5 years at a rate of 22.2% per year.
Versnelling van de groei: Unable to compare HONGSENG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: HONGSENG is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (1.6%).
Rendement op eigen vermogen
Hoge ROE: HONGSENG has a negative Return on Equity (-21.92%), as it is currently unprofitable.